Discover 754 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 754
E-STIM Trial: Comparing the Efficacy of the Empi Select TENS to a Control for the Treatment of Chronic Lower Back Pain
for
Lower Back Pain
Location: Perrysburg OH, Bloomington IL, Reston VA, Marietta GA,
Sponsor: Empi, A DJO Company
Sex: All
Age: 18 - 65
Code: NCT00709748
Recruiting
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
for
Pancreatic Cancer, Metastatic,
Location: Maumee OH, Summit NJ, New York NY
Sponsor: Engeneic Pty Limited
Sex: All
Age: 18+
Code: NCT07049055
Phase1, Phase2, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Maumee OH, Columbus OH, Pittsburgh PA, Chicago IL,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase2, Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: Maumee OH, Goshen IN, Canton OH, Hinsdale IL, Peoria IL,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: Maumee OH, Indianapolis IN, Arlington Heights IL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06581432
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Toledo OH, Grand Rapids MI, Bethesda MD, Orange City FL,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase3, Recruiting
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)